As Vice President of pharma strategy for Europe, Graham Lewis is responsible for developing and conducting Strategic Management Reviews (SMR) for senior management of pharmaceutical companies at a global, regional and local level.
Over the past decade, Lewis has increasingly focused on strategic issues within the pharma industry, with particular emphasis on geographical growth opportunities, mergers and acquisitions, portfolio planning and forecasting. He has worked extensively in oncology from early stage compound evaluation through market assessment, strategic planning and business development.
An economist by profession, Lewis entered the pharmaceutical industry in 1973 when he accepted a position at Eli Lilly. He subsequently moved to the service side of the industry, with Medical Market Studies Limited (MMSL), where he became managing director of MMSL in 1978. He continued in this role until MMSL merged with IMS into the IMS Pharma Strategy group in 1992.
Lewis has spoken at conferences in Western Europe, North America, Latin America and the Far East, including China -- and is widely sought after for his strategic insights. In May of 2002, Lewis was awarded the first ever Lifetime Achievement Award given by the Pharmaceutical Business Intelligence and Research Group (PBIRG) in recognition of his “outstanding lifetime contributions to the pharmaceutical industry and market research profession.”
